Uniting Discovery and Care: The Role of Pharmaceutical Companies in Research, Clinical Studies, and Patient Care

Chenyun Tan; James M McGill; Lotus Mallbris

doi:10.1016/j.jid.2020.01.007

Uniting Discovery and Care: The Role of Pharmaceutical Companies in Research, Clinical Studies, and Patient Care

J Invest Dermatol. 2020 Mar;140(3):527-530. doi: 10.1016/j.jid.2020.01.007. Epub 2020 Jan 20.

Authors

Chenyun Tan¹, James M McGill¹, Lotus Mallbris²

Affiliations

¹ Eli Lilly and Company, Indianapolis, Indiana, USA.
² Eli Lilly and Company, Indianapolis, Indiana, USA. Electronic address: [email protected].

PMID: 31972248
DOI: 10.1016/j.jid.2020.01.007

Abstract

In an era of increased complexity of clinical research, a demand for personalized medicine, an increasing value of diversity, a focus on digital health, and a call for patient centricity, the discovery and development of new medicines, more than ever, is dependent on collaboration between multiple stakeholders.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Clinical Trials as Topic / organization & administration
Drug Development / organization & administration*
Drug Industry / organization & administration*
Humans
Intersectoral Collaboration*
Patient-Centered Care / organization & administration*
Translational Research, Biomedical / organization & administration*